dual BET/CDK9 inhibitors (Xuzhou Medical University/Chinese Academy of Sciences)

N/A

Report date: 2025/03/19 09:00:14
NME

Base Information

Drug Namedual BET/CDK9 inhibitors (Xuzhou Medical University/Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsBromodomain-containing protein 4 inhibitors
TargetsBromodomain-containing protein 4Cyclin-dependent kinase 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXuzhou Medical University (Xzmu)
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of SciencesXuzhou Medical University (Xzmu)
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A